NextCure, Inc. (NXTC)
NGS · Common · CUSIP 65343E108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for NXTC and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
65343E108
Market Cap
Small Cap
IPO
5/9/2019 · $15.00/share
Business: NextCure, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases.

Company Contact

CEO
Michael Richman
CFO
Steven P. Cobourn
Headquarters
9000 Virginia Manor Road, Suite 200, Beltsville, MD 20705
Phone
240-399-4900
Investor Relations
Timothy Mayer · 240-762-6486 · IR@nextcure.com
General Email
info@nextcure.com
SEC EDGAR Filings
View filings »